263 related articles for article (PubMed ID: 29422060)
21. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies.
Aly AA; El-Sheref EM; Bakheet MEM; Mourad MAE; Brown AB; Bräse S; Nieger M; Ibrahim MAA
Bioorg Chem; 2018 Dec; 81():700-712. PubMed ID: 30268050
[TBL] [Abstract][Full Text] [Related]
23. Quinoline-based clioquinol and nitroxoline exhibit anticancer activity inducing FoxM1 inhibition in cholangiocarcinoma cells.
Chan-On W; Huyen NT; Songtawee N; Suwanjang W; Prachayasittikul S; Prachayasittikul V
Drug Des Devel Ther; 2015; 9():2033-47. PubMed ID: 25897210
[TBL] [Abstract][Full Text] [Related]
24. Naphthoquinone-Quinolone Hybrids with Antitumor Effects on Breast Cancer Cell Lines-From the Synthesis to 3D-Cell Culture Effects.
da Gama Oliveira V; Muxfeldt M; Muniz da Paz M; Silva Coutinho M; Eduardo Dos Santos R; Diniz da Silva Ferretti G; Ferraz da Costa DC; Fonseca Regufe P; Lelis Gama I; da Costa Santos Boechat F; Silva Lima E; Ferreira VF; de Moraes MC; Bastos Vieira de Souza MC; Netto Batalha P; Pereira Rangel L
Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928197
[TBL] [Abstract][Full Text] [Related]
25. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
26. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
[TBL] [Abstract][Full Text] [Related]
27. YM155 and BIRC5 downregulation induce genomic instability via autophagy-mediated ROS production and inhibition in DNA repair.
Cheng SM; Lin TY; Chang YC; Lin IW; Leung E; Cheung CHA
Pharmacol Res; 2021 Apr; 166():105474. PubMed ID: 33549731
[TBL] [Abstract][Full Text] [Related]
28. Cytoprotective effect of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) is mediated by the inhibition of BAK-dependent mitochondrial apoptosis pathway.
Jun DY; Jang WY; Kim KY; Woo MH; Kim YH
PLoS One; 2018; 13(10):e0204585. PubMed ID: 30273361
[TBL] [Abstract][Full Text] [Related]
29. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L
Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333
[TBL] [Abstract][Full Text] [Related]
30. Discovery and synthesis of sulfur-containing 6-substituted 5,8-dimethoxy-1,4-naphthoquinone oxime derivatives as new and potential anti-MDR cancer agents.
Huang G; Dong JY; Zhang QJ; Meng QQ; Zhao HR; Zhu BQ; Li SS
Eur J Med Chem; 2019 Mar; 165():160-171. PubMed ID: 30677614
[TBL] [Abstract][Full Text] [Related]
31. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
[TBL] [Abstract][Full Text] [Related]
32. Pre-Clinical Activity of Amino-Alcohol Dimeric Naphthoquinones as Potential Therapeutics for Acute Myeloid Leukemia.
Ferraris D; Lapidus R; Truong P; Bollino D; Carter-Cooper B; Lee M; Chang E; LaRossa-Garcia M; Dash S; Gartenhaus R; Choi EY; Kipe O; Lam V; Mason K; Palmer R; Williams E; Ambulos N; Kamangar F; Zhang Y; Kapadia B; Jing Y; Emadi A
Anticancer Agents Med Chem; 2022; 22(2):239-253. PubMed ID: 34080968
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
Li X; Li Z; Li X; Liu B; Liu Z
BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
[TBL] [Abstract][Full Text] [Related]
34. Designing new iridium(iii) arene complexes of naphthoquinone derivatives as anticancer agents: a structure-activity relationship study.
Tabrizi L; Chiniforoshan H
Dalton Trans; 2017 Feb; 46(7):2339-2349. PubMed ID: 28138683
[TBL] [Abstract][Full Text] [Related]
35. The role of thioredoxin reductase and glutathione reductase in plumbagin-induced, reactive oxygen species-mediated apoptosis in cancer cell lines.
Hwang GH; Ryu JM; Jeon YJ; Choi J; Han HJ; Lee YM; Lee S; Bae JS; Jung JW; Chang W; Kim LK; Jee JG; Lee MY
Eur J Pharmacol; 2015 Oct; 765():384-93. PubMed ID: 26341012
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticancer activity of some novel 5,6-fused hybrids of juglone based 1,4-naphthoquinones.
Mallavadhani UV; Prasad CV; Shrivastava S; Naidu VG
Eur J Med Chem; 2014 Aug; 83():84-91. PubMed ID: 24953027
[TBL] [Abstract][Full Text] [Related]
37. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
Hsu YL; Cho CY; Kuo PL; Huang YT; Lin CC
J Pharmacol Exp Ther; 2006 Aug; 318(2):484-94. PubMed ID: 16632641
[TBL] [Abstract][Full Text] [Related]
38. Novel juglone and plumbagin 5-O derivatives and their in vitro growth inhibitory activity against apoptosis-resistant cancer cells.
Fiorito S; Genovese S; Taddeo VA; Mathieu V; Kiss R; Epifano F
Bioorg Med Chem Lett; 2016 Jan; 26(2):334-337. PubMed ID: 26706169
[TBL] [Abstract][Full Text] [Related]
39. Anticancer Effects and Mechanisms of Action of Plumbagin: Review of Research Advances.
Yin Z; Zhang J; Chen L; Guo Q; Yang B; Zhang W; Kang W
Biomed Res Int; 2020; 2020():6940953. PubMed ID: 33344645
[TBL] [Abstract][Full Text] [Related]
40. Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cells.
Wang F; Wang Q; Zhou ZW; Yu SN; Pan ST; He ZX; Zhang X; Wang D; Yang YX; Yang T; Sun T; Li M; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():537-60. PubMed ID: 25632222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
